APA (7th ed.) Citation

Martínez Lago, N., Alonso de Castro, B., Varela Ponte, R., Reboredo Rendo, C., Gomez-Randulfe Rodriguez, M., Graña Suarez, B., . . . Reboredo-Lopez, M. (2021). P-31 Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies. Annals of Oncology, 32, S106. https://doi.org/10.1016/j.annonc.2021.05.086

Chicago Style (17th ed.) Citation

Martínez Lago, N., et al. "P-31 Real-world Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies." Annals of Oncology 32 (2021): S106. https://doi.org/10.1016/j.annonc.2021.05.086.

MLA (9th ed.) Citation

Martínez Lago, N., et al. "P-31 Real-world Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies." Annals of Oncology, vol. 32, 2021, p. S106, https://doi.org/10.1016/j.annonc.2021.05.086.